(Bloomberg) A Massachusetts priest who moonlights as a hedge fund manager was sued by federal regulators for allegedly making false statements about a biotech company to try to drive down its share price. In an attempt to profit from his short position, Emmanuel Lemelson published false “research reports” about Ligand Pharmaceuticals Inc. on popular investing websites, including Seeking Alpha, according to a complaint filed Wednesday by the U.S. Securities and Exchange Commission.
Hedge Fund Priest Sued by SEC for Alleged Stock Manipulation
This entry was posted in Syndicated. Bookmark the permalink.
